Oral Bruton tyrosine kinase inhibitors block activation of...

Blood Advances 2019 / 12 Vol. 3; Iss. 23

Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?

Goldmann, Luise, Duan, Rundan, Kragh, Thorsten, Wittmann, Georg, Weber, Christian, Lorenz, Reinhard, von Hundelshausen, Philipp, Spannagl, Michael, Siess, Wolfgang
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2019000617
Date:
December, 2019
File:
PDF, 1.40 MB
2019
Conversion to is in progress
Conversion to is failed